Entering into joint venture contracts between Shanghai Zuquan Investment Management Company Limited on one side and Epygon, Kephalios and MyoPowers on the other side.
Recent Posts
- Affluent Medical Announces Progress Toward European Clinical Study of Artificial Sphincter Artus for the Treatment of Urinary Stress Incontinence in Women
- Affluent Medical announces several key appointments for Medical and Clinical affairs
- Affluent Medical appoints Liane Teplitsky as a new member of the Board of Directors
- 10th successful human implantation of Artus urinary sphincter, marking completion of the pilot phase
-
Presentation at LSI Europe ’24
Emerging MedTech Summit 2024 (Lisbon)
Sébastien Ladet, CEO
Recent Comments